NCT02192814 - Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset Seizures | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

December 31, 2014

Conditions

EpilepsyPartial-onset Seizures

Interventions

DRUG

Lacosamide (200 mg/20 mL)

"Active Substance: Lacosamide~Pharmaceutical form: Solution for intravenous (iv) infusion~Concentration: adapted on concentration of oral dose in EP0009~Route of Administration: Drip infusion"

Trial Locations (5)

Unknown

81027, Hamamatsu

81024, Kodaira

81025, Sapporo

81003, Shizuoka

81023, Suita